Csaba Szabo

This inventor holds 21 USPTO granted patents, plus 4 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag, Biogal Gyogyszergyar Rt., Corus Pharma, Inc.. Active years: 1994-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Csaba Szabo. Retrieved from https://idiyas.com/inventor/csaba-szabo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21

% Patents Active = 42.9

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 35(Granted Patents)

Location History:

Debreen, HU (2007)
Hajduboszormeny, HU (2008)
Debrecen, HU (1994 - 2010)
Gyor, HU (2014)

Company Filing History:

8 out of 26

Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag

patents

4 out of 26

Biogal Gyogyszergyar Rt.

Teva Gyogyszergyar Reszvenytarsasag

patents

5. 1 out of 1

“Avidin” Kutato, Fejleszto Es Kereskedelmi Korlatolt Felelossegu Tarsasag

Teva Gyógyszergyár Zárkörüen Müködö Részvénytársaság

patent

8. 1 out of 1

Teva Gyógyszergyár Zártkörüen Müködö Részvénytárasaság

patent

9. 1 out of 1

Teva Gyógyszergyár Zártkörún Müködö Részvénytársaság

patent

10. 1 out of 1

Ubichem Kutato Korlatolt Felelossegu Tarsasag

patent

where one patent can have more than one assignee

Years Active: 1994-2014

Loading Chart...

Areas of Expertise:

8-Hydroxy-Quinoline Derivatives

Mupirocin Calcium

Dolasetron Production

Pimecrolimus

Aztreonam Polymorphs

Mycophenolate Sodium

Macrolide Extraction

Pravastatin Sodium

Controlled Simvastatin

Deferoxamine Salts

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8871937 - 8-hydroxy-quinoline derivatives (2014-10-28),

2. 7737177 - Processes for preparing crystalline and amorphous mupirocin calcium (2010-06-15),

3. 7608714 - Production of dolasetron (2009-10-27),

4. 7589128 - Process for preparation of amorphous form of a drug (2009-09-15),

5. 7589100 - Non-hygroscopic and powdery amorphous pimecrolimus (2009-09-15),

6. 7452991 - Aztreonam β polymorph with very low residual solvent content (2008-11-18),

7. 7439373 - Crystalline mycophenolate sodium (2008-10-21),

8. 7432074 - Method for extracting a macrolide from biomatter (2008-10-07),

9. 7358093 - Aztreonam L-lysine and methods for the preparation and analysis thereof (2008-04-15),

10. 7279571 - Methods of preparing pimecrolimus (2007-10-09),

11. 7262293 - Aztreonam L-lysine and methods for the preparation thereof (2007-08-28),

12. 7262218 - Forms of pravastatin sodium (2007-08-28),

13. 7145017 - Preparation of Aztreonam (2006-12-05),

14. 7098345 - Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one (2006-08-29),

15. 7001919 - Forms of pravastatin sodium (2006-02-21),

Title: Csaba Szabo - Innovative Inventor from Debrecen, HU

Introduction: Csaba Szabo is a renowned inventor hailing from Debrecen, Hungary, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Csaba Szabo holds several patents in the areas of renewable energy, nanotechnology, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With over two decades of experience in the industry, Csaba Szabo has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized their respective fields.

Collaborations: Throughout his career, Csaba Szabo has collaborated with top companies, patent attorneys, and fellow inventors to bring his ideas to life and ensure their successful implementation in the market.

Conclusion: Csaba Szabo's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers, making him a true pioneer in the world of technology and science.

Profile summary based on public USPTO records.